These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 372207)

  • 1. Abnormal plasma catecholamine responses in acromegalics.
    Van Loon GR
    J Clin Endocrinol Metab; 1979 May; 48(5):784-9. PubMed ID: 372207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma norepinephrine and epinephrine in acromegaly.
    Cryer PE
    J Clin Endocrinol Metab; 1975 Sep; 41(3):542-5. PubMed ID: 1159061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders.
    Van Loon GR
    Metabolism; 1980 Nov; 29(11 Suppl 1):1198-202. PubMed ID: 7432178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of bromocriptine to lower plasma catecholamines in normal men and women.
    Bybee DE; Wiesen M; Aronin N; Krieger DT; Frohman LA; Kopin IJ
    J Clin Endocrinol Metab; 1982 Mar; 54(3):648-50. PubMed ID: 6276434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thyrotrophin-releasing hormone on plasma catecholamine levels in acromegalics.
    Rozenberg I; Manchon P; Sabatier C; Hazard J; Lhoste F
    Acta Endocrinol (Copenh); 1985 May; 109(1):19-24. PubMed ID: 3923755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of the dopamine agonist bromocriptine on the postcastration gonadotrophin rise in women.
    Melis GB; Paoletti AM; Mais V; Gambacciani M; Guarnieri G; Strigini F; Fruzzetti F; Fioretti P
    J Clin Endocrinol Metab; 1981 Sep; 53(3):530-5. PubMed ID: 6790558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.
    Arosio M; Moriondo P; Travaglini P; Ambrosi B; Beck-Peccoz P; Puglisi FC; Secchi F; Faglia G
    J Clin Endocrinol Metab; 1980 Sep; 51(3):454-61. PubMed ID: 6773973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 11. Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF.
    Van Loon GR
    Nature; 1978 Sep; 275(5678):331-2. PubMed ID: 357990
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of bromocriptine on plasma catecholamines in normal men.
    Van Loon GR; Sole MJ; Bain J; Ruse JL
    Neuroendocrinology; 1979; 28(6):425-34. PubMed ID: 460538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma.
    Van Loon GR
    Lancet; 1978 Oct; 2(8095):868-71. PubMed ID: 81414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
    Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
    Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopausal flushes: a neuroendocrine link with pulsatile luteninizing hormone secreation.
    Casper RF; Yen SS; Wilkes MM
    Science; 1979 Aug; 205(4408):823-5. PubMed ID: 462193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.
    Pieters GF; Romeijn JE; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 May; 54(5):942-8. PubMed ID: 6120951
    [No Abstract]   [Full Text] [Related]  

  • 19. Diurnal rhythm of plasma catecholamines in acromegaly.
    Bondanelli M; Ambrosio MR; Franceschetti P; Margutti A; Trasforini G; Degli Uberti EC
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2458-67. PubMed ID: 10404821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-releasing action of LRF: a central catecholamine mediated event?
    Zhang YW; Yen SS
    Life Sci; 1984 Feb; 34(7):653-7. PubMed ID: 6366415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.